AbbVie, Voyager Launch Up-to-$1.1B+ Gene-Therapy Collaboration to Treat Alzheimer’s, Neurodegenerative Diseases – Genetic Engineering & Biotechnology News
Boston Business Journal |
AbbVie, Voyager Launch Up-to-$1.1B+ Gene–Therapy Collaboration to Treat Alzheimer's, Neurodegenerative Diseases
Genetic Engineering & Biotechnology News AbbVie will partner with Voyager Therapeutics to develop and commercialize gene therapies for Alzheimer's disease and other neurodegenerative diseases, through a collaboration that could generate more than $1.1 billion-plus for Voyager, the companies … Cambridge's Voyager, AbbVie to pursue Alzheimer's gene therapy under $69M deal With $69M Deal, AbbVie Turns to Voyager for an Alzheimer's Gene Therapy AbbVie steers past the wreckage, reserves $224M to kick off once-and-done gene therapy with Voyager to fight … |
